Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

BCX9930, a Potent, Selective, Oral Factor D Inhibitor, Demonstrates Proof-of-Concept As Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Austin Kulasekararaj, MD MRCP, FRCPath, Jacques Le Roux Malherbe, MD, Andrew McDonald, Melanie Cornpropst, PharmD, PhD, Phil Collis, PhD, Matthew Davidson, PharmD, Xilin Chen, MDPhD, Kristin Tower, Diane Gesty-Palmer, MD PhD, William P. Sheridan, MBBS, Antonio Risitano

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-138838

Published: 2020

Journal Articles

BCX9930, an Oral Factor D Inhibitor, for the Potential Treatment of Alternative Pathway Mediated Diseases: Interim Results of a Phase 1 Study in Healthy Subjects

Matthew Davidson, PharmD, Amanda Mathis, PhD, Stuart Mair, MBChB, DRCOG, DCPSA, FFPM, Diane Gesty-Palmer, MD PhD, Melanie Cornpropst, PharmD, PhD, William P. Sheridan, MBBS, Xilin Chen, MDPhD, David Reynolds, BS MT, Cynthia Parker, BS, Yarlagadda S. Babu, PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-138475

Published: 2020